• Crown to get North American rights of GSK’s OTC drugs namely- PanOxyl- Sarna- Zeasorb- Desenex- Mineral Ice
• The focus of the acquisition is to build Crown’s footprints in North America with expansion of its consumer portfolio to treat multiple conditions
• Products with indication: PanOxyl is an acne wash- Sarna is an anti-itch lotion- Zeasorb is an anti-fungal and prevention product- Desenex is an anti-fungal for athlete’s foot & Mineral Iceis a pain-relieving gel

Ref: Crown Laboratories  | Image: GSK